Biologic Use in Children and Adolescents
Copyright :
Monoclonal antibodies, plasma-derived proteins, and recombinant human proteins are increasingly being used in children and adolescents. In this session, you will analyze the evidence for their safety and efficacy in the treatment of the most common chronic inflammatory diseases.
Teri Woo, PhD, ARNP, CPNP-PC, CNL, FAANP, is professor and director of nursing at Saint Martin’s University in Lacey, Washington. She completed her BSN, MSN and post Masters PNP certificate at Oregon Health Sciences University, and her PhD in nursing at University of Colorado Denver College of Nursing. Dr. Woo is a Fellow of the American Association of Nurse Practitioners and lead author of Pharmacotherapeutics for Advanced Practice Nurse Prescribers and has written and lectured extensively in the area of nurse practitioner prescribing and pediatric pharmacology. She served on the NAPNAP board from 2017 to 2021 and has served on the Pediatric Nurse Certification Board Pharmacology CE committee since 2002. Dr. Woo practices as a PNP-PC at Mary Bridge Children’s Hospital Urgent Care in Washington.
Speaker Disclosures: